Trilogy Metals Inc. TMQ
We take great care to ensure that the data presented and summarized in this overview for Trilogy Metals Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding TMQ
View all-
John Paulson Paulson & Co. Inc. | New York, Ny14.3MShares$15.5 Million0.47% of portfolio
-
Old West Investment Management, LLC Los Angeles, CA7.83MShares$8.46 Million1.53% of portfolio
-
Tsp Capital Management Group, LLC5.22MShares$5.64 Million0.86% of portfolio
-
Wexford Capital LP Greenwich, CT4.57MShares$4.94 Million0.57% of portfolio
-
Goehring & Rozencwajg Associates, LLC New York, NY1.67MShares$1.8 Million0.17% of portfolio
-
Sprott Inc. Toronto, A61.27MShares$1.37 Million0.04% of portfolio
-
Toroso Investments, LLC Massapequa, NY1.07MShares$1.15 Million0.01% of portfolio
-
Manufacturers Life Insurance Company, The Toronto, A6578KShares$624,7280.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny427KShares$461,1430.0% of portfolio
-
Alps Advisors Inc Denver, CO297KShares$321,0810.0% of portfolio
Latest Institutional Activity in TMQ
Top Purchases
Top Sells
About TMQ
Trilogy Metals Inc., a base metals exploration company, explores for and develops mineral properties in the United States. It principally holds interests in the Upper Kobuk mineral projects that include the Arctic, which contains polymetallic volcanogenic massive sulfide deposits; and Bornite that contains carbonate-hosted copper - cobalt deposits covering an area of approximately 426,690 acres located in the Ambler mining district in Northwest Alaska. The company was formerly known as NovaCopper Inc. and changed its name to Trilogy Metals Inc. in September 2016. Trilogy Metals Inc. was founded in 2004 and is headquartered in Vancouver, Canada.
Insider Transactions at TMQ
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 09
2024
|
Tony Giardini President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
801,400
+5.89%
|
-
|
|
Dec 09
2024
|
Elaine Sanders VP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
175,000
+5.71%
|
-
|
|
Dec 09
2024
|
Elaine Sanders VP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
104,750
+3.71%
|
-
|
|
Dec 02
2024
|
Elaine Sanders VP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
44,545
+1.68%
|
-
|
|
Dec 02
2024
|
Tony Giardini President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
131,313
+2.21%
|
-
|
|
Sep 03
2024
|
Elaine Sanders VP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
63,079
+2.4%
|
-
|
|
Sep 03
2024
|
Tony Giardini President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
185,714
+3.17%
|
-
|
|
Jun 05
2024
|
Elaine Sanders VP & CFO |
SELL
Open market or private sale
|
Direct |
53,454
-2.09%
|
$0
$0.49 P/Share
|
|
Jun 04
2024
|
Elaine Sanders VP & CFO |
SELL
Open market or private sale
|
Direct |
94,287
-3.56%
|
$0
$0.5 P/Share
|
|
Jun 03
2024
|
Elaine Sanders VP & CFO |
SELL
Open market or private sale
|
Direct |
152,259
-5.43%
|
$0
$0.5 P/Share
|
|
Jun 03
2024
|
Elaine Sanders VP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
68,859
+2.4%
|
-
|
|
Jun 03
2024
|
Tony Giardini President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
203,125
+3.57%
|
-
|
|
Mar 08
2024
|
Elaine Sanders VP & CFO |
SELL
Open market or private sale
|
Direct |
15,008
-0.55%
|
$0
$0.44 P/Share
|
|
Mar 07
2024
|
Elaine Sanders VP & CFO |
SELL
Open market or private sale
|
Direct |
4,992
-0.18%
|
$0
$0.45 P/Share
|
|
Mar 01
2024
|
Tony Giardini President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
220,339
+4.01%
|
$8,813,560
$40.0 P/Share
|
|
Mar 01
2024
|
Elaine Sanders VP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
74,705
+2.64%
|
-
|
|
Feb 21
2024
|
Elaine Sanders VP & CFO |
SELL
Open market or private sale
|
Direct |
100
-0.0%
|
$0
$0.46 P/Share
|
|
Feb 16
2024
|
Elaine Sanders VP & CFO |
SELL
Open market or private sale
|
Direct |
358
-0.01%
|
$0
$0.46 P/Share
|
|
Feb 15
2024
|
Elaine Sanders VP & CFO |
SELL
Open market or private sale
|
Direct |
55,737
-2.04%
|
$0
$0.46 P/Share
|
|
Feb 14
2024
|
Elaine Sanders VP & CFO |
SELL
Open market or private sale
|
Direct |
200
-0.01%
|
$0
$0.46 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 1.9M shares |
|---|---|
| Exercise of conversion of derivative security | 834K shares |
| Open market or private sale | 502K shares |
|---|